BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 15026566)

  • 1. Possible association of acute lateral-wall myocardial infarction and bitter orange supplement.
    Nykamp DL; Fackih MN; Compton AL
    Ann Pharmacother; 2004 May; 38(5):812-6. PubMed ID: 15026566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Consumption of dietary supplements containing Citrus aurantium (bitter orange)--2004 California Behavioral Risk Factor Surveillance Survey (BRFSS).
    Klontz KC; Timbo BB; Street D
    Ann Pharmacother; 2006 Oct; 40(10):1747-51. PubMed ID: 16968826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The safety of Citrus aurantium (bitter orange) and its primary protoalkaloid p-synephrine.
    Stohs SJ; Preuss HG; Shara M
    Phytother Res; 2011 Oct; 25(10):1421-8. PubMed ID: 21480414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Availability of weight-loss supplements: Results of an audit of retail outlets in a southeastern city.
    Sharpe PA; Granner ML; Conway JM; Ainsworth BE; Dobre M
    J Am Diet Assoc; 2006 Dec; 106(12):2045-51. PubMed ID: 17126636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ischemic colitis associated with use of a bitter orange-containing dietary weight-loss supplement.
    Sultan S; Spector J; Mitchell RM
    Mayo Clin Proc; 2006 Dec; 81(12):1630-1. PubMed ID: 17165643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ephedra-associated cardiomyopathy.
    Naik SD; Freudenberger RS
    Ann Pharmacother; 2004 Mar; 38(3):400-3. PubMed ID: 14742827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mass spectrometric determination of the predominant adrenergic protoalkaloids in bitter orange (Citrus aurantium).
    Nelson BC; Putzbach K; Sharpless KE; Sander LC
    J Agric Food Chem; 2007 Nov; 55(24):9769-75. PubMed ID: 17966980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Citrus aurantium and synephrine alkaloids in the treatment of overweight and obesity: an update.
    Haaz S; Fontaine KR; Cutter G; Limdi N; Perumean-Chaney S; Allison DB
    Obes Rev; 2006 Feb; 7(1):79-88. PubMed ID: 16436104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bitter orange weight loss products may not be safe.
    Health News; 2004 Dec; 10(12):9. PubMed ID: 15645567
    [No Abstract]   [Full Text] [Related]  

  • 10. Exactly which synephrine alkaloids does Citrus aurantium (bitter orange) contain?
    Allison DB; Cutter G; Poehlman ET; Moore DR; Barnes S
    Int J Obes (Lond); 2005 Apr; 29(4):443-6. PubMed ID: 15700046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of nonprescription dietary supplements for weight loss is common among Americans.
    Blanck HM; Serdula MK; Gillespie C; Galuska DA; Sharpe PA; Conway JM; Khan LK; Ainsworth BE
    J Am Diet Assoc; 2007 Mar; 107(3):441-7. PubMed ID: 17324663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Products containing bitter orange or synephrine: suspected cardiovascular adverse reactions.
    Jordan S; Murty M; Pilon K
    CMAJ; 2004 Oct; 171(8):993-4. PubMed ID: 15497209
    [No Abstract]   [Full Text] [Related]  

  • 13. Herbal weight-loss supplement misadventures per a regional poison center.
    Robinson RF; Griffith JR; Nahata MC; Mahan JD; Casavant MJ
    Ann Pharmacother; 2004 May; 38(5):787-90. PubMed ID: 15044657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Response of CEDIA amphetamines assay after a single dose of bitter orange.
    Nguyen DT; Bui LT; Ambrose PJ
    Ther Drug Monit; 2006 Apr; 28(2):252-4. PubMed ID: 16628139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood pressure and heart rate effects following a single dose of bitter orange.
    Bui LT; Nguyen DT; Ambrose PJ
    Ann Pharmacother; 2006 Jan; 40(1):53-7. PubMed ID: 16317106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Risk assessment of synephrine in dietary supplements].
    Bakhyia N; Dusemund B; Richter K; Lindtner O; Hirsch-Ernst KI; Schäfer B; Lampen A
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2017 Mar; 60(3):323-331. PubMed ID: 28058460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety of herbal supplements: a guide for cardiologists.
    Cohen PA; Ernst E
    Cardiovasc Ther; 2010 Aug; 28(4):246-53. PubMed ID: 20633025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physiological effects following administration of Citrus aurantium for 28 days in rats.
    Hansen DK; George NI; White GE; Pellicore LS; Abdel-Rahman A; Fabricant D;
    Toxicol Appl Pharmacol; 2012 Jun; 261(3):236-47. PubMed ID: 22521485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A case report of atrial fibrillation potentially induced by hydroxycut: a multicomponent dietary weight loss supplement devoid of sympathomimetic amines.
    Karth A; Holoshitz N; Kavinsky CJ; Trohman R; McBride BF
    J Pharm Pract; 2010 Jun; 23(3):245-9. PubMed ID: 21507821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute tubular necrosis associated with chromium picolinate-containing dietary supplement.
    Wani S; Weskamp C; Marple J; Spry L
    Ann Pharmacother; 2006 Mar; 40(3):563-6. PubMed ID: 16492795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.